Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

tDCS plus cognitive training to improve thinking in persistent post-concussion syndrome

Official title: Effects of Transcranial Direct Current Stimulation for Enhancing Cognitive Function in Individuals With Persistent Post-Concussion Syndrome: A Pilot fMRI/1H-MRS Study

Run by The Hong Kong Polytechnic University · NCT06376500 · Data updated 2026-11-12

This trial will test whether gentle electrical brain stimulation (tDCS) combined with cognitive training can improve thinking and memory in adults with ongoing post-concussion symptoms from a mild head injury 1–6 years ago.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Hung Hom, Kowloon)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedAugust 2027
Study endsFebruary 2028
Registry record updatedSeptember 25, 2026
Trial IDNCT06376500 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with a confirmed mild TBI 1–6 years ago who still have cognitive symptoms and can communicate in Chinese are ideal candidates.

Probably not a fit

People with other neurological or psychiatric disorders, implanted devices, pregnancy, recent medical instability, or an inability to undergo MRI or follow the protocol are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The program enrolls adults (≥18) with a confirmed mild traumatic brain injury 1–6 years prior who continue to have cognitive symptoms and can communicate in Chinese. Participants receive repeated sessions of transcranial direct current stimulation (tDCS) paired with a structured cognitive training program delivered in-person. Cognitive performance and brain measures (fMRI and magnetic resonance spectroscopy) are collected before and after the intervention to track changes in cognition, cortical connectivity, and excitatory/inhibitory balance. Key exclusions include other neurological or psychiatric disorders, implanted devices, pregnancy, recent medical instability, and inability to tolerate MRI.

Why it matters

Potential benefit: If successful, this approach could reduce persistent cognitive symptoms and improve daily functioning for people with chronic post-concussion syndrome.

How similar studies have gone: Previous small trials of tDCS with cognitive training after TBI have shown mixed but sometimes promising results, so the approach has pilot support but is not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* being 18 years old or older;
* having a history of a mild TBI (less than 30 minutes loss of consciousness) 1-6 years prior to the study;
* able to communicate in Chinese.

Exclusion Criteria:

* being without a confirmed diagnosis from the medical practitioner;
* having a history of other neurological and psychiatric disorders, skull defect, recent medical instability (within 3 weeks);
* being pregnant;
* being medication for a psychiatric condition (e.g., major depression, anxiety, schizophrenia);
* with any implanted devices or suffering from real claustrophobia or feel uncomfortable in small, enclosed spaces, like MRI tunnel

Where it's running

  • The Hong Kong Polytechnic University
    Hung Hom, Kowloon, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.